Publication | Open Access

Histone deacetylase (HDAC) inhibitors targeting HDAC3 and HDAC1 ameliorate polyglutamine-elicited phenotypes in model systems of Huntington's disease

ChromatinChromatin RemodelingEpigenetic ChangeGeneticsPolyglutamine-elicited PhenotypesModel SystemsEpigenomicsMolecular BiologyDisease Gene IdentificationNeurodegenerationSystems BiologyMedicineEpigenetics